ISTURISA ® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize hypercortisolemia in Cushing’s syndrome, a rare endocrine condition that can have significant ...
(RTTNews) - Xeris Biopharma Holdings Inc. (XERS) said Monday that the U.S. Food and Drug Administration granted its subsidiary Xeris Pharmaceuticals Inc., orphan-drug exclusivity for Recorlev ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results